Brookstone Capital Management Sells 1,821 Shares of CME Group Inc. $CME

Key Points

• Brookstone Capital Management reduced its stake in CME Group Inc. by 21.6%, selling 1,821 shares in the second quarter, bringing its total holdings to 6,592 shares valued at approximately $1.8 million.
• Insider Timothy Francis Mccourt sold 379 shares of CME Group on September 16th, indicating a 3.83% decrease in his holdings, while Director William R. Shepard purchased 262 shares, reflecting a small increase in ownership.
• CME Group's recent earnings report showed an EPS of $2.68, beating expectations, but revenue declined by 3.0% year-over-year to $1.54 billion.

Brookstone Capital Management trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 21.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 6,592 shares of the financial services provider's stock after selling 1,821 shares during the period. Brookstone Capital Management's holdings in CME Group were worth $1,817,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CME. Wayfinding Financial LLC bought a new position in shares of CME Group during the 1st quarter worth about $25,000. Webster Bank N. A. lifted its holdings in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after purchasing an additional 60 shares during the last quarter. Cornerstone Planning Group LLC lifted its holdings in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. Highline Wealth Partners LLC lifted its holdings in CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares in the company, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William R. Shepard purchased 262 shares of the stock in a transaction dated Thursday, September 25th. The shares were acquired at an average price of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 in the last 90 days. Corporate insiders own 0.30% of the company's stock.

CME Group Trading Up 0.2%

Shares of NASDAQ CME opened at $269.54 on Friday. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The company has a market cap of $97.14 billion, a PE ratio of 26.12, a P/E/G ratio of 6.18 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average of $266.47 and a two-hundred day moving average of $271.67.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts' consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $2.68 earnings per share. The company's revenue was down 3.0% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's payout ratio is currently 48.45%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. TD Cowen lifted their price target on shares of CME Group from $288.00 to $290.00 and gave the company a "hold" rating in a report on Thursday. Weiss Ratings reissued a "buy (b)" rating on shares of CME Group in a report on Friday. Piper Sandler lifted their price target on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. UBS Group cut their price target on shares of CME Group from $285.00 to $280.00 and set a "neutral" rating for the company in a report on Thursday. Finally, Raymond James Financial cut their price target on shares of CME Group from $309.00 to $307.00 and set an "outperform" rating for the company in a report on Monday, October 13th. Eight investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, CME Group currently has a consensus rating of "Hold" and an average price target of $284.53.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.